HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

890.408

-22.370-2.45%

Number of Gainers:1

Number of Losers:16

Number of Flat:- -

PE:- -

High:911.751

Open:911.751

Low:887.660

Close:912.778

Volume:390.86M

Turnover:2.96B

Market Cap:600.58B

Float Cap:498.11B

Loading ...

Alibaba Health Information Technology Stock Slips 2.9% in Hong Kong

Sinopharm Group Stock Slips 2.1% in Hong Kong

BYD Electronic (International) Stock Sheds 2.4% in Hong Kong

Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors

JD Health International Stock Sheds 3.7% in Hong Kong

AH Share Premium Rankings as of September 9 Trading Close

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

Dizal Pharmaceutical's Birelentinib Shows Promise in Lymphoma Study Published in Blood Cancer Journal

BOC International sees pharma sector earnings recovery as industry enters a reversal cycle

Ascletis Hits 4-Week High on Initiating US Phase I Study on Obesity Drug

TYK Medicines-B Chairman, President and CEO Wu Yusheng Plans Share Purchase

Harvest Machinery Accelerates Autumn Grain Collection in Garzê, Sichuan

Genfleet-B Completes Share Buyback Worth HK$1.54 Million

ALEBUND-B Wins US FDA Nod to Start Trial of Novel IgA Nephropathy Drug AP308

CSPC Pharmaceutical Gets China Approval for Eye Drug Clinical Trials

MT Newswires Live

ASC36 Obesity Therapy Enters Phase I Trials in the US by Ascletis

Ascletis Pharma - Initiates U.S. Phase I Study for Asc36 Oral Tablets for Obesity

THOMSON REUTERS

SBP Group Unveils Preclinical Findings for Oral STAT6 Degrader TQH5528 at ERS 2026

Sino Biopharm Presents ERS 2026 Preclinical Data for Oral STAT6 Degrader Tqh5528

CSPC Wins China Clinical Trial Approval for Syh2083 Dry Eye Drops

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BK1515/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":890.4082,"timestamp":1789027721934,"preClose":912.77844,"halted":0,"volume":390861706,"delay":0,"changeRate":-0.024508,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-22.370239,"latestTime":"09-10 16:00:00","open":911.75104,"high":911.75104,"low":887.6602,"amount":2960733819,"amplitude":0.026393,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"pbRate":1.367616,"peRate":17.723048,"turnoverRate":0.005102,"increases":1,"decrements":16,"flats":0,"marketCap":600577450304,"floatMarketCap":498112716352},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":911.75104,"amplitude":0.026393,"preClose":912.77844,"low":887.6602,"pbRate":"1.367616","latestPrice":890.4082,"volume":390861706,"delay":0,"open":911.75104,"prevYearClose":1190.107,"prevWeekClose":936.431,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":925.365,"twentyDayClose":923.05,"sixtyDayClose":869.522,"secType":"PLATE","market":"HK","turnoverRate":0.005102,"peRate":17.723048,"marketCap":600577450304,"floatMarketCap":498112716352,"timestamp":1789027721934,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":1,"down":16,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666585460","title":"Alibaba Health Information Technology Stock Slips 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666585460","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666585460?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. shed 2.9% to 3.05 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.This was the stock's second consecutive day of losses.Alibaba Health Information Technology Ltd. closed 61% short of its 52-week high of HK$7.91, which the company reached Jan. 14.The stock underperformed when compared to some of its competitors, as HKT Trust & HKT Ltd. fell 0.1%.Trading volume totaled 82.0 million shares, compared to the 50-day average of 97.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSI","07500","09115","BK1589","BK1247","03419","07200","02833","BK1502","513600","MHImain","BK1571","BK1584","02800","BK1501","HSTECH","BK1515","MCHmain","BK1610","BK1617","83115","03037","BK1615","BK1142","HHImain","82800","HK0000165453.HKD","07300","BK1591","BK1189","03115","00241"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458549","title":"Sinopharm Group Stock Slips 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458549","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458549?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 2.1% to 15.70 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.The stock's fall snapped a four-day winning streak.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.2%.Trading volume totaled 5.9 million shares, compared to the 50-day average of 5.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK1191","BK0012","BK0187","BK0028","BK1593","BK1197","BK0196","600196","BK0239","LU1115378108.SGD","BK0183","BK0096","SHTDY","BK1515","02196","BK1500","01099","BK4175","BK0175","LU0640798160.USD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666427585","title":"BYD Electronic (International) Stock Sheds 2.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666427585","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666427585?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. slipped 2.4% to 24.90 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.This was the stock's second consecutive day of losses.BYD Electronic  Co. Ltd. closed 44% below its 52-week high of HK$44.60, which the company reached Oct. 2.Despite its losses, the stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. fell 3.1%.Trading volume totaled 9.3 million shares, compared to the 50-day average of 12.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00285","BK1582","BK1589","BK1167","BK1504","BK1540","BK1607","LU0348766576.USD","LU0274383008.USD","BK1149","LU0348767384.USD","BK1515","BK1580"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666854905","title":"Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666854905","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666854905?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:31","pubTimestamp":1788942660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 4.0% to 5.61 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.Sino Biopharmaceutical Ltd. closed 38% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.4% and Amgen Inc. remained unchanged.Trading volume totaled 97.7 million shares, compared to the 50-day average of 100.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IBB","LU0289739699.SGD","IE00B2B36J28.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","BK1191","LU0889565916.HKD","IE0002141913.USD","BK1521","IE00BZ08YS42.EUR","LU2089984988.USD","LU1023059063.AUD","PJP","BK1589","IE00BZ08YR35.GBP","LU2242646821.SGD","BK4599","BK4533","BBH","LU1571399168.USD","AMGN","BK4139","BK4534","LU2242652126.USD","LU2468319806.SGD","TBXU","BK4581","HK0000165453.HKD","IE00B4R5TH58.HKD","IE0009355771.USD","BK4566","BK4588","01177","LU0058720904.USD","LU0122379950.USD","LU0320765992.SGD","LU1983299246.USD","IBBQ","BK1515","BK4585","LU1057294990.SGD","LU2112291526.USD","LU0868494617.USD","SG9999001440.SGD","BIB","IE00BJT1NW94.SGD","IE00BZ08YT58.USD","PBE","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666585445","title":"JD Health International Stock Sheds 3.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666585445","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666585445?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:30","pubTimestamp":1788942600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. shed 3.7% to 35.26 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.This was the stock's third consecutive day of losses.JD Health International Inc. closed 51% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 20.2 million shares, compared to the 50-day average of 9.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1571","BK1591","SGXZ62798434.SGD","BK1142","06618","BK1615","LU0051755006.USD","BK1589","SGXZ86797644.SGD","BK1583","LU0456827905.SGD","BK1247","86618"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194600066","title":"AH Share Premium Rankings as of September 9 Trading Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1194600066","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194600066?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:24","pubTimestamp":1788942275,"startTime":"0","endTime":"0","summary":"As of the market close on September 9, three companies lead the A-H share premium rankings for the session. NE ELECTRIC (00042) tops the list with a premium of 1121.72%, followed by ZHEJIANG SHIBAO...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1140","LU0348814723.USD","LU0821914370.USD","83130","LU1794554557.SGD","LU1808992512.USD","02846","02475","LU1961090484.USD","LU0828237510.HKD","BK1594","LU0886674414.USD","HK0000320223.HKD","LU1303224171.USD","LU2097828474.EUR","LU0082770016.SGD","LU0329678170.USD","LU0469268626.HKD","LU0348816934.USD","LU2394011477.USD","LU0287142896.SGD","03308","BK1144","BK1193","BK1537","BK1161","LU0269904917.USD","LU1720050803.USD","00300","LU1282648689.USD","LU2097828557.USD","LU0039217434.USD","SG9999002463.SGD","01033","BK1583","BK1147","LU0211977185.USD","LU2097828805.USD","BK1554","LU0543330483.HKD","BK1110","LU0165289439.USD","LU0307460666.USD","LU0672654166.SGD","BK1551","BK1546","LU0449509016.USD","BK1249","IE0032431581.USD","LU0370786039.SGD","BK1231","LU0828238088.HKD","03986","LU0607220059.USD","LU0052750758.USD","LU0348825331.USD","LU0345780281.USD","LU1770034418.SGD","00895","LU2177674079.SGD","LU1255011170.USD","01812","399300","BK1190","LU0128522157.USD","LU0417516738.SGD","SG9999001093.SGD","BK1148","LU1105468828.SGD","02338","LU0106959298.USD","LU0588546209.SGD","BK1564","BK1171","BK1552","IE00BZ08YS42.EUR","HK0001040168.HKD","IE0034224299.USD","06745","LU0320764599.SGD","LU0431992006.USD","BK1163","LU0359201885.HKD","82846","BK1116","159982","BK1560","00042","LU2039709279.SGD","BK1202","BK1530","LU1152091168.USD","LU2242644610.SGD","BK1523","BK1191","LU1188198961.HKD","LU1328277881.USD","06869","LU0029875118.USD","BK1149","LU0214875030.USD","LU1813983027.USD","09976","02218","LU0164865239.USD","03678","LU1807302812.USD","LU0417516902.SGD","LU0871576103.HKD","BK1170","LU2045819591.USD","03130","LU0359202008.SGD","LU1046422090.SGD","HK0001040143.USD","LU0737861699.HKD","LU0314109678.HKD","LU1769817179.HKD","LU0345780521.USD","LU0540923850.HKD","LU2008162690.USD","BK1223","LU0164880469.USD","LU0359201612.USD","01057","LU0067412154.USD","IE00B0169L03.USD","LU0561508036.HKD","LU0531971595.HKD","02068","LU0061477393.USD","LU1244550221.USD","00187","02899","BK1214","LU2226246903.HKD","LU0326950275.SGD","LU1152091754.HKD","01108","LU0868486357.SGD","00553","BK1122","BK1514","LU0049853897.USD","BK1141","LU1224709979.USD","LU1048596156.SGD","LU1481107354.HKD","07233","LU0509642566.USD","SG9999011746.SGD","LU0149721374.USD","BK1105","LU0173614495.USD","83188","SG9999006597.SGD","03750","LU1244550577.SGD","BK1198","LU1244550494.USD","LU0082770016.USD","LU1008478684.HKD","LU0228659784.USD","BK1592","01349","01877","LU1242518857.USD","LU0918141705.HKD","LU0463099449.HKD","BK1544","LU0531970944.HKD","IE00BZ08YT58.USD","LU0254981946.USD","LU0181495838.USD","LU1242518931.SGD","LU2543165471.USD","LU0328353924.USD","BK1576","01276","LU1831875114.USD","LU3063872942.SGD","BK1533","LU0327786744.USD","LU0348827113.USD","LU1988902786.USD","BK1515","SG9999014674.SGD","BK1610","LU0043850808.USD","LU0244354667.USD","LU0979878070.USD","03328","LU2097828631.EUR","LU1251922891.USD","HK0000320264.USD","LU2264538146.SGD","LU0149534421.HKD","LU0266512473.USD","00317","03188","BK1506","IE00BZ08YR35.GBP","06821","LU0348766576.USD","LU1719994722.HKD","BK1505","LU0737861772.HKD","LU1206782309.USD","LU0329678337.USD","00991","LU0634319403.HKD","LU1064131342.USD","LU2125910500.SGD","LU0348735423.USD","02827","LU2399975544.HKD","06066","LU0918141887.USD","03200","LU1655091616.SGD","LU0456854461.SGD","EWH","02359","LU0320764755.SGD","LU2097828714.EUR","SG9999004220.SGD","LU1504937902.USD","LU0797268264.HKD","LU1769817096.USD","LU0048580855.USD","LU1960683339.HKD","LU0572944931.SGD","BK1237","BK1562","LU0096374516.USD","LU0106252389.USD","LU0164939612.USD","LU0880133367.SGD","BK1522","HK0000306685.HKD","02865","BK1125","LU0140636845.USD","LU0708995583.HKD","SG9999001226.SGD","LU1023057109.AUD","LU1993786604.SGD","LU0620787316.HKD","LU0266512127.USD","LU0828237940.HKD","BK1183","LU0348767384.USD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143782105","title":"UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick","url":"https://stock-news.laohu8.com/highlight/detail?id=1143782105","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143782105?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:03","pubTimestamp":1788940980,"startTime":"0","endTime":"0","summary":"UBS has released a research report indicating that first-half results among Chinese pharmaceutical stocks were mixed, with five of the nine rated companies exceeding market expectations. These...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","01530","03692","BK1589","BK1593","IE00BZ08YR35.GBP","BK1515","IE00BZ08YT58.USD","BK1161","BK1521","IE00B3M56506.USD","BK1191","03933","01477","HK0000165453.HKD","02096","BK1583","01177","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144997108","title":"Dizal Pharmaceutical's Birelentinib Shows Promise in Lymphoma Study Published in Blood Cancer Journal","url":"https://stock-news.laohu8.com/highlight/detail?id=1144997108","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144997108?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:00","pubTimestamp":1788940815,"startTime":"0","endTime":"0","summary":"Dizal Pharmaceutical Co., Ltd. (688192.SH) has announced that the results of its Phase II clinical study, TAI-SHAN9, evaluating the company's first-in-class, fully brain-penetrant, non-covalent...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688192","159938","BK1161","09939","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112577285","title":"BOC International sees pharma sector earnings recovery as industry enters a reversal cycle","url":"https://stock-news.laohu8.com/highlight/detail?id=1112577285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112577285?lang=en_us&edition=fundamental","pubTime":"2026-09-09 11:30","pubTimestamp":1788924637,"startTime":"0","endTime":"0","summary":"The pharmaceutical sector's interim reports for the first half of 2026 have been fully released, revealing resilient overall growth with structural improvements continuing to unfold, according to BOC...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","159938","BK1161","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309337","title":"Ascletis Hits 4-Week High on Initiating US Phase I Study on Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309337","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309337?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:03","pubTimestamp":1788919398,"startTime":"0","endTime":"0","summary":"BUZZ-Ascletis hits 4-week high on initiating US Phase I study on obesity drug** Shares of Ascletis Pharma Inc1672.HKclimb 5.6% to HK$10.75, their highest since August 13** Stock on track for biggest one-day pct gain since August 7** Pharmaceutical products producer says it hasinitiateda U.S. Phase I study of ASC36 oral tablets for treatment of obesity after receiving Investigational New Drug clearance from the U.S. Food and Drug Administration** ASC36 oral tablets reduced mean body weight up to 13.2% from baseline after once-daily dosing for seven days in non-human primates - co** YTD, stock down 7.3%, while Hang Seng Biotech Index.HSBIOup 10.7%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL1N451020:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","BK1574","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136667600","title":"TYK Medicines-B Chairman, President and CEO Wu Yusheng Plans Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1136667600","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136667600?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:26","pubTimestamp":1788873985,"startTime":"0","endTime":"0","summary":"TYK Medicines-B (02410) has announced that its Chairman, Executive Director and President, Dr. Wu Yusheng, has informed the company of his recent share purchases in the open market. Dr. Wu may...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","02410","BK1161","BK1574","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176903440","title":"Harvest Machinery Accelerates Autumn Grain Collection in Garzê, Sichuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1176903440","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176903440?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:10","pubTimestamp":1788873056,"startTime":"0","endTime":"0","summary":"On September 8, combine harvesters were deployed to assist in gathering highland barley in Gexia Village, Xise Township, Garzê County.September marks the peak autumn harvest season across the Garzê...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00241","BK1617","BK1571","BK1610","HK0000165453.HKD","BK1584","BK1589","BK1189","BK1591","BK1142","BK1515","BK1615","BK1502","BK1501","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126663144","title":"Genfleet-B Completes Share Buyback Worth HK$1.54 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1126663144","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126663144?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:11","pubTimestamp":1788869514,"startTime":"0","endTime":"0","summary":"On September 8, 2026, GENFLEET-B (02595) announced that it had repurchased a total of 57,000 shares at a cost of HK$1.5418 million.The buyback was executed in accordance with the company's existing...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1574","BK1515","159938","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141807270","title":"ALEBUND-B Wins US FDA Nod to Start Trial of Novel IgA Nephropathy Drug AP308","url":"https://stock-news.laohu8.com/highlight/detail?id=1141807270","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141807270?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:06","pubTimestamp":1788869176,"startTime":"0","endTime":"0","summary":"ALEBUND-B (09637) has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for AP308, a first-in-class engineered recombinant IgA...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","IBBJ","BK1191","09637","BK1515","PSYK","BK1161","159938","MDTX","159151","09939","BMED","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665214203","title":"CSPC Pharmaceutical Gets China Approval for Eye Drug Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2665214203","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665214203?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:13","pubTimestamp":1788862439,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group's (HKG:1093) SYH2083 eye drops received approval from the National Medical Products Administration to begin clinical trials in China.The class 1 innovative drug is being developed for dry eye disease, according to a Tuesday Hong Kong bourse filing.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B5MMRT66.SGD","LU1951186391.HKD","LU1226287792.SGD","01093","HK0000165453.HKD","IE00B543WZ88.USD","LU1993786604.SGD","LU2039709279.SGD","BK1521","LU0072913022.USD","IE0008369823.USD","LU0501845795.SGD","LU0314109678.HKD","LU1807302812.USD","LU0880133367.SGD","BK1515","LU1960683339.HKD","LU1813983027.USD","LU1226287875.USD","LU1152091754.HKD","LU0315179316.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU1226288253.USD","LU1152091168.USD","LU0326950275.SGD","LU1226287529.USD","LU0140636845.USD","LU0067412154.USD","IE0008368742.USD","SG9999004220.SGD","LU1226288170.HKD","KURE","BK1191","LU1008478684.HKD","LU1328277881.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164928784","title":"ASC36 Obesity Therapy Enters Phase I Trials in the US by Ascletis","url":"https://stock-news.laohu8.com/highlight/detail?id=1164928784","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164928784?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:06","pubTimestamp":1788861983,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) has announced the initiation of its Phase I clinical study in the United States for ASC36, an oral amylin receptor agonist peptide designed to treat obesity, following...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1515","BK1161","BK1574","BK1191","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665932180","title":"Ascletis Pharma - Initiates U.S. Phase I Study for Asc36 Oral Tablets for Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2665932180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665932180?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:01","pubTimestamp":1788861676,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN44Z0L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127409678","title":"SBP Group Unveils Preclinical Findings for Oral STAT6 Degrader TQH5528 at ERS 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1127409678","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127409678?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:54","pubTimestamp":1788861263,"startTime":"0","endTime":"0","summary":"SBP GROUP has announced that its subsidiary, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., presented preclinical study data for TQH5528, an oral STAT6 degrader, at the European Respiratory...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00BZ08YR35.GBP","01177","HK0000165453.HKD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1515","BK1521","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665291593","title":"Sino Biopharm Presents ERS 2026 Preclinical Data for Oral STAT6 Degrader Tqh5528","url":"https://stock-news.laohu8.com/highlight/detail?id=2665291593","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665291593?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:51","pubTimestamp":1788861070,"startTime":"0","endTime":"0","summary":"Sino Biopharm presents ERS 2026 preclinical data for oral STAT6 degrader TQH5528Sino Biopharmaceutical disclosed preclinical data for TQH5528, an oral STAT6 degrader, already presented at ERS 2026.Stu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLb1BcpX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","IE00BZ08YR35.GBP","01177","IE00BZ08YS42.EUR","BK1521","BK1191","IE00BZ08YT58.USD","HK0000165453.HKD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329613","title":"CSPC Wins China Clinical Trial Approval for Syh2083 Dry Eye Drops","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329613","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329613?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:47","pubTimestamp":1788860844,"startTime":"0","endTime":"0","summary":"CSPC wins China clinical trial approval for SYH2083 dry eye dropsCSPC received China NMPA clearance to start clinical trials of SYH2083 eye drops, a small-molecule novel drug.Initial indication target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL4D1fT5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU1226288170.HKD","LU1152091168.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","LU0501845795.SGD","LU1226287529.USD","IE0008369823.USD","LU0880133367.SGD","SG9999004220.SGD","LU0315179316.USD","LU1226287875.USD","HK0000165453.HKD","IE00B543WZ88.USD","LU1960683339.HKD","LU1328277881.USD","LU1807302812.USD","LU1951186391.HKD","LU1226288253.USD","LU0072913022.USD","LU0140636845.USD","IE0008368742.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","BK1515","LU0067412154.USD","BK1521","BK1191","LU1008478684.HKD","IE00B5MMRT66.SGD","KURE","LU1993786604.SGD","01093","LU1152091754.HKD","IE00B031HY20.USD","IE00BZ08YT58.USD","LU1813983027.USD","LU0314109678.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}